StockData
Xeris Biopharma Holdings, Inc. logo

Xeris Biopharma Holdings, Inc. (XERS) stock

XERSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30
$16.97+0.35 (+2.11%)

Close on Nov 20, 2026Market cap $3.09BP/E –Yield –

Xeris Biopharma pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Xeris Biopharma's pe ratio was 161.6× on Jul 31, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 2026161.6×–

More Xeris Biopharma figures

See a number that looks wrong?